Parkinson's Research Ventures
Discover how the programme works, what it's achieved, and how you can support our groundbreaking research.
Parkinson's Research Ventures is a specialised global programme that aims to accelerate the development of transformative treatments for Parkinson's.
This Parkinson’s UK-led initiative, run in partnership with the Parkinson's Foundation, is powered by the Parkinson’s community to ensure that the research we fund aligns with real-world needs.
We’ve committed over £30 million to projects pushing new treatments forward. This early support has been instrumental in attracting millions in follow-on funding, accelerating the journey of new treatments closer to the people living with Parkinson's.
How does Parkinson’s Research Ventures work?
We carefully select the projects with the greatest potential to improve life for people with Parkinson’s. We invest in rapidly testing and developing them.
We act as investors, with the experts and resources to actively monitor and manage each project. We understand the drug development business and are driven by results. But because it’s driven by people with Parkinson’s, not by profits, we’ll invest where others won’t.
We provide Pre-Seed, Seed, and Series A funding to high-potential pre-clinical and clinical programs that aim to modify disease progression or significantly improve the management of specific symptoms.
By funding critical milestones, we significantly decrease the risk profile of novel assets, making them highly attractive for downstream acquisition or late-stage venture participation.
Explore our projects
We're investing in a wide range of projects pursuing treatments with the potential to make a life-changing impact for people living with Parkinson’s.
These include pioneering projects developing new drugs in the lab, alongside groundbreaking clinical trials testing promising new treatments in people with Parkinson's.
Work with Parkinson's Research Ventures
We invest in drug discovery and clinical trials to accelerate life-changing new treatments for people with the condition.
We’re always looking for new projects and opportunities to drive forward better treatments for Parkinson’s, including both disease-modifying and symptomatic treatments.
Collaboration on a global scale
Parkinson’s Research Ventures is made up of:
-
a core team of biotech professionals experienced in neurological and Parkinson's drug development, with established relationships across companies, investors, and partners
-
over 60 funders, research organisations, universities, biotech companies, trial centres, and charities worldwide
- a long term, multi-million dollar strategic partnership with the Parkinson’s Foundation
- thousands of generous supporters uniting to find a cure.
Everyone can play a part in the search for a cure for Parkinson's. From funding to volunteering, the more people who get involved, the faster we'll get there.
Partner with us as a major donor
We build long-term partnerships with philanthropists, grant-making trusts, foundations and companies who all play a pivotal role in funding breakthroughs.